France Radiation Oncology Market Size & Outlook, 2020-2028
France radiation oncology market, 2017-2028 (US$M)
Related Markets
France radiation oncology market highlights
- The France radiation oncology market generated a revenue of USD 289.9 million in 2020 and is expected to reach USD 521.6 million by 2028.
- The France market is expected to grow at a CAGR of 7.6% from 2021 to 2028.
- In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
- Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
Radiation oncology market data book summary
| Market revenue in 2020 | USD 289.9 million |
| Market revenue in 2028 | USD 521.6 million |
| Growth rate | 7.6% (CAGR from 2020 to 2028) |
| Largest segment | External beam radiationtherapy |
| Fastest growing segment | Internal Beam Radiation Therapy |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
Other key industry trends
- In terms of revenue, France accounted for 3.8% of the global radiation oncology market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, Germany radiation oncology market is projected to lead the regional market in terms of revenue in 2028.
- UK is the fastest growing regional market in Europe and is projected to reach USD 500.6 million by 2028.
External beam radiationtherapy was the largest segment with a revenue share of 67.06% in 2020. Horizon Databook has segmented the France radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
The radiation oncology market in France is expected to witness significant growth over the forecast period owing to the rapid commercialization of new products in the country. For instance, in July 2018, ViewRay.
The distribution of the company’s proprietary product, MRIdian Linac, in a network of 19 cancer care hospitals. Furthermore, in June 2017, Accuray, Inc. announced the installation of smart Radixact Treatment Delivery System in the University Cancer Institute of Toulouse.
Moreover, presence of Directive 2001/20/EC of 4 April 2001, which is related to the implementation of good clinical practice in study of nuclear medicinal products for human use, is expected to drive the market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiation Oncology Market Scope
Radiation Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France radiation oncology market size, by type, 2017-2028 (US$M)
France Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
